With the rapid introduction of novel breast cancer therapies, recognizing and managing side effects is essential to maintain adherence and improve outcomes. As novel oral endocrine therapies and ...
Law that takes effect April 1 grants too much power to government and too little protection to medical professionals ...
As we move into the warmer weather, a well-known gay doctor has issued a reminder to people who are taking DoxyPEP. DoxyPEP ...
The Food and Drug Administration issued a warning letter to Novo Nordisk — the maker of Ozempic and Wegovy — for failing to report potential side effects in patients who took its blockbuster ...
Novo Nordisk, the pharmaceutical company behind Ozempic, has received a warning letter from the U.S. Food and Drug Administration over issues with its procedures for reporting potential side effects ...
Novo Nordisk NOVO.B-0.87%decrease; red down pointing triangle received a warning from the Food and Drug Administration for failing to report serious suspected side effects in patients who took the ...
Feb 26 (Reuters) - Eli Lilly's (LLY.N), opens new tab experimental weight-loss pill, orforglipron, caused more side effects and treatment discontinuations than Novo Nordisk's (NOVOb.CO), opens new tab ...
I am currently arranging to get a shingles vaccination. I had shingles at university and still bear the scars, so I really don’t want to risk getting it again. But I also have in mind the fact that ...
It’s worth the weight — loss, that is. Despite their blockbuster popularity, GLP-1 medications come with a handful of side effects, mainly along the lines of gastrointestinal issues like nausea and ...
A massive review of 23 randomized trials found that statins do not cause the vast majority of side effects listed on their labels. Memory problems, depression, sleep issues, weight gain, and many ...
The long list of side effects marked on the packaging of statins can be a turn-off for those who might benefit from the cholesterol-lowering drugs. But a new study found only a few of those side ...